OID,Drug Name,SMILES,molecular_weight,logP,pKa,solubility
1,dextromethorphan,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,271.401 g/mol,,,
2,salicylamide,C1=CC=C(C(=C1)C(=O)N)O,137.1373 g/mol,,,5.5
3,albuterol (salbutamol),CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,239.31 g/mol,,,
4,clofibrate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,242.701 g/mol,,,
5,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,336.476 g/mol,,8.4,
6,verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,454.607 g/mol,,,
7,sulindac,CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,356.415 g/mol,,,
8,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,261.087 g/mol,,,
9,pentobarbital,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,226.2742 g/mol,,,
10,vecuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,637.738 g/mol,,,
11,terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,548.6 g/mol,,,
12,doxycycline,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,444.438 g/mol,,,
13,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,250.199 g/mol,,,0.0055
14,valproic acid,CCCC(CCC)C(=O)O,144.212 g/mol,,,
15,methoxsalen (8-methoxypsoralen),COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,216.191 g/mol,1.9,,
16,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,241.2885 g/mol,,,0.04
17,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,328.41 g/mol,3.1,,
18,ranitidine,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C,314.408 g/mol,,,
19,nisoldipine,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,388.418 g/mol,3.18,,
20,prednisone,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,358.4 g/mol,,,0.168
21,terfenadine,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,471.681 g/mol,7.1,,0.0000963
22,azlocillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C,461.497 g/mol,,,
23,ciprofibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,289.1566 g/mol,,,
24,idrocilamide,C1=CC=C(C=C1)/C=C/C(=O)NCCO,191.229 g/mol,0.9,,
25,primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,259.351 g/mol,,,
26,proguanil,CC(C)N=C(N)/N=C(\N)/NC1=CC=C(C=C1)Cl,253.735 g/mol,,,
27,decitabine,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O,228.21 g/mol,,,5.5
28,atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,266.34 g/mol,,9,10^-2
29,netilmicin,CCN[C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]2[C@@H]([C@H]([C@@](CO2)(C)O)NC)O)O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N,475.5829 g/mol,,,
30,minocycline,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,457.48 g/mol,,,
31,nitrazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,281.2699 g/mol,,,
32,atropine,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,289.373 g/mol,,,
33,moxonidine,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,241.6808 g/mol,,,
34,enalapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,376.45 g/mol,,,
35,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,234.341 g/mol,2.44,8.01,
36,clindamycin,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,424.987 g/mol,,,
37,progesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,314.5 g/mol,,,
38,levothyroxine (thyroxine),C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N,776.855 g/mol,,2.2,
39,cicletanine,CC1=NC=C2C(OCC2=C1O)C3=CC=C(C=C3)Cl,261.7068 g/mol,,,
40,roxatidine,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,306.403 g/mol,,,
41,viloxazine,CCOC1=CC=CC=C1OCC2CNCCO2,237.297 g/mol,,,43
42,tamoxifen,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,371.5 g/mol,7.1,9.24,
43,indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,357.791 g/mol,,,
44,ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,204.312 g/mol,,,
45,zopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,388.8133 g/mol,,,
46,prednisolone,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,360.4 g/mol,,,
47,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,307.395 g/mol,,,
48,fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,306.275 g/mol,,,
49,sulbactam,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C,233.2429 g/mol,,,
50,bevantolol,CC1=CC(=CC=C1)OCC(CNCCC2=CC(=C(C=C2)OC)OC)O,345.436 g/mol,,,
51,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,365.839 g/mol,,,
52,alfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,416.523 g/mol,,,
53,misoprostol acid,CCCCC(C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O,368.51 g/mol,,,
54,ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,554.5872 g/mol,,,
55,sulfisoxazole,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,267.31 g/mol,,,
56,pirenzepine,CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,351.4079 g/mol,,,
57,carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,236.273 g/mol,,,
58,stiripentol,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O,234.29 g/mol,,,
59,nicotine,CN1CCC[C@H]1C2=CN=CC=C2,162.2346 g/mol,,,
60,bezafibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,361.823 g/mol,,,
61,ticarcillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C,384.431 g/mol,,,
62,clobazam,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,300.7437 g/mol,,,
63,ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,206.283 g/mol,,,
64,nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,346.337 g/mol,2.2,,0.0055
65,cisapride,CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,465.95 g/mol,,,
66,clofibric acid,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,214.6469 g/mol,,,
67,pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,248.7 g/mol,,,
68,josamycin,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,827.999 g/mol,2.9,,
69,midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,325.773 g/mol,2.5,5.5,
70,cefoperazone,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,645.6753 g/mol,,,
71,tolfenamic acid,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,261.7068 g/mol,,,
72,ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,361.368 g/mol,,,
73,flunarizine,C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,404.501 g/mol,1.97,10,5.5
74,triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,343.216 g/mol,,,
75,gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,446.908 g/mol,4.15,5.42,
76,allopurinol,C1=NNC2=C1C(=O)NC=N2,136.114 g/mol,,,
77,alogliptin,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N,339.3969 g/mol,-0.9,8.5,19.2
78,vigabatrin,C=CC(CCC(=O)O)N,129.158 g/mol,,,
80,apremilast,CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,460.5 g/mol,,,
81,sacubitrilat,C[C@H](C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O)C(=O)O,383.4 g/mol,,,
82,nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,418.443 g/mol,,,
83,propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,178.273 g/mol,,11,
84,ramipril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,416.515 g/mol,,,
85,avatrombopag,C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl,649.6646 g/mol,,,
86,rosuvastatin (acid),CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,481.5 g/mol,,,
87,desvenlafaxine (O-desmethylvenlafaxine),CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,263.38 g/mol,,,
88,deoxycholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,392.576 g/mol,,,
89,lesinurad,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,404.28 g/mol,4.7,,
90,lacosamide,CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1,250.30 g/mol,,,
91,abiraterone acetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,391.6 g/mol,5.12,5.19,
92,darolutamide,C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,398.8521 g/mol,,,
93,ibudilast,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,230.3092 g/mol,,,
94,nalidixic acid,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,232.238 g/mol,,,
95,indinavir,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,613.798 g/mol,2.8,,
96,sparfloxacin,C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,392.404 g/mol,,,
97,tenapanor,CN1C[C@H](C2=C(C1)C(=CC(=C2)Cl)Cl)C3=CC(=CC=C3)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C4=CC=CC(=C4)[C@@H]5CN(CC6=C5C=C(C=C6Cl)Cl)C,1145.0614 g/mol,,,
98,perindopril,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,368.471 g/mol,,,
99,doravirine,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,425.75 g/mol,3,9.47,0.0055
100,imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,589.7 g/mol,3.5,,21.5
101,halofantrine,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,500.429 g/mol,8.86,,
102,tipranavir,CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,602.671 g/mol,6.9,,
103,valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O,435.525 g/mol,4.4,4,0.55
104,glimepiride,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,490.622 g/mol,,,
105,simeprevir,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,749.94 g/mol,,,
106,glyburide (glibenclamide),COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,494.009 g/mol,,,
107,notoginsenoside R1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,933.131 g/mol,,,
108,evacetrapib,CC1=CC(=C2C(=C1)[C@H](CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,638.6534 g/mol,,,
109,doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,543.5 g/mol,,,
110,propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,259.347 g/mol,,,
111,palonosetron,C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5,296.412 g/mol,,,
112,simvastatin (lactone),CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,418.7 g/mol,,,
113,bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,364.42 g/mol,,,
114,everolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,958.232 g/mol,,,
115,bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,358.2669 g/mol,,,
116,pefloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,333.361 g/mol,,,
117,cefpirome,CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-],514.5848 g/mol,,,
118,brexpiprazole,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,433.2 g/mol,,7.8,
119,carebastine,CC(C)(C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)O,499.647 g/mol,,,
120,semaglutide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC6=CN=CN6)N,4113.6119 g/mol,,,
121,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,250.336 g/mol,,4.7,
122,vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,489.93 g/mol,3,7.9,0.0055
124,falnidamol,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl,387.8481 g/mol,1.83,2.83,
125,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,321.162 g/mol,,,
126,fexofenadine (terfenadine carboxylate),CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,501.663 g/mol,,,
127,sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N,523.32 g/mol,,,
128,N-desethylsunitinib (SU12662),CCNCCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,370.4 g/mol,,,
129,nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,479.53 g/mol,3.82,,
130,melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,232.2814 g/mol,0.8,16.51,
131,brotizolam,CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4Cl,393.695 g/mol,,,
132,ciclesonide,CC(C)C(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)O[C@H](O2)C6CCCCC6,540.7 g/mol,,,
133,gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,323.4149 g/mol,,5.8,
135,dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,248.305 g/mol,,,
136,desmethylselegiline,C[C@H](CC1=CC=CC=C1)NCC#C,173.2575 g/mol,2.46,9.8,
137,saxagliptin,C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N,333.43 g/mol,,,
138,acetaminophen (paracetamol),CC(=O)NC1=CC=C(C=C1)O,151.16 g/mol,,,
139,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,335.47 g/mol,,,
140,chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,,,,
141,miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,407.571 g/mol,,,
142,naphthoquine,CC(C)(C)NCC1=CC(=C2CCCCC2=C1O)NC3=C4C=CC(=CC4=NC=C3)Cl,409.9582 g/mol,6.08,,
143,dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,441.57 g/mol,0.93,7.89,
144,daclatasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,738.885 g/mol,,,
145,cefepime,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-],480.5676 g/mol,,,
146,doripenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O,420.50 g/mol,,,
147,contezolid,C1CN(C=CC1=O)C2=C(C=C(C(=C2F)F)N3C[C@@H](OC3=O)CNC4=NOC=C4)F,408.3345 g/mol,,,
148,BMS-690514,COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CC[C@H]([C@@H](C4)O)N,368.4386 g/mol,1.53,4.3,
149,trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,693.53 g/mol,4.99,0.25,
151,tepotinib,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,492.5802 g/mol,,9.5,0.55
152,ampicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C,371.39 g/mol,,,
153,fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,393.39 g/mol,4.26,2.78,0.0007
154,pravastatin (acid),CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,424.53 g/mol,1.6,4.2,21.5
155,tovorafenib,C[C@H](C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl,506.285 g/mol,3.63,10.29],
156,meropenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O,437.52 g/mol,,,
157,zidovudine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],267.244 g/mol,,,
158,lusutrombopag,CCCCCCO[C@@H](C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)/C=C(\C)/C(=O)O)Cl,591.5 g/mol,,,
159,fasiglifam,CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)[C@@H](CO4)CC(=O)O)C)OCCCS(=O)(=O)C,524.6 g/mol,,,
160,irosustat,C1CCC2=C(CC1)C(=O)OC3=C2C=CC(=C3)OS(=O)(=O)N,309.3405 g/mol,,,
162,lenabasum (ajulemic acid),CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C(=O)O)O,400.5554 g/mol,1.84,5.13,
164,oxymorphone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,337.80 g/mol,,,
165,agomelatine,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,243.304 g/mol,,,
166,enoximone,CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC,248.305 g/mol,,,
167,doxepin,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,279.4 g/mol,,8.96,0.934
168,captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,217.288 g/mol,,,
169,bromocriptine,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,654.602 g/mol,,,
171,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,263.382 g/mol,,9.7,
172,dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,519.57 g/mol,2.9,6.6,
173,mosapride,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N,421.8975 g/mol,,,
174,tolrestat,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,357.3506 g/mol,,,
175,meloxicam,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,351.4 g/mol,3,4.08,
176,inclisiran,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4C[C@@H](C[C@H]4COP(=O)(O)O)O)CO)O)O,17284.72 g/mol,-8,,
177,cefatrizine,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)CSC4=NNN=C4,462.5092 g/mol,,,
178,letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,285.30 g/mol,,,
179,dexmethylphenidate,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2,233.3091 g/mol,1.8,,
180,ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,319.229 g/mol,,,
181,maribavir,CC(C)NC1=NC2=CC(=C(C=C2N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl,376.24 g/mol,2.86,5.2,
182,durlobactam,CC1=C[C@@H]2CN([C@@H]1C(=O)N)C(=O)N2OS(=O)(=O)O,277.2559 g/mol,,,
183,nitisinone,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],329.229 g/mol,1.6,,0.0055
184,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,213.663 g/mol,,,
185,thiabendazole,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,201.252 g/mol,2.47,4.64,0.05
186,perampanel,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,362.90 g/mol,,3.24,0.0018
187,ginsenoside Rg1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C,801.0168 g/mol,,,
188,ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,532.56 g/mol,5.14,2.77,0.16
189,edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,548.065 g/mol,,,
190,budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,430.5 g/mol,,,0.0055
191,ibrexafungerp,C[C@H](C(C)C)[C@]1(CC[C@@]2([C@H]3CC[C@H]4[C@]5(COC[C@]4(C3=CC[C@]2([C@@H]1C(=O)O)C)C[C@H]([C@@H]5OC[C@@](C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C,730.0443 g/mol,,,
192,naltrexone,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,341.405 g/mol,,,
193,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,295.405 g/mol,,,
194,ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,720.955 g/mol,3.9,,0.0055
195,ombitasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,894.1203 g/mol,,,0.0055
196,fluticasone propionate,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,500.5749 g/mol,,,
197,pancuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,732.677 g/mol,,,
198,bendazac,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O,282.298 g/mol,,,
200,levetiracetam,CC[C@@H](C(=O)N)N1CCCC1=O,170.2106 g/mol,,,
201,binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,441.2305 g/mol,,,
202,terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,387.438 g/mol,,,
204,metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,299.8 g/mol,,,
205,dagrocorat,CC1=C(C=CC=N1)NC(=O)C2=CC3=C(C=C2)[C@@]4(CC[C@@](C[C@H]4CC3)(C(F)(F)F)O)CC5=CC=CC=C5,494.5541 g/mol,,,
206,levomethadyl acetate,CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,353.503 g/mol,,,
207,delafloxacin,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,440.76 g/mol,,,
208,bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,470.61 g/mol,,,
209,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,428.537 g/mol,4.1,,
210,(l)-nebivolol,C1CC2=C(C=CC(=C2)F)O[C@H]1[C@H](CNC[C@@H]([C@@H]3CCC4=C(O3)C=CC(=C4)F)O)O,405.4 g/mol,,,
211,carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],373.2666 g/mol,,,
212,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,266.303 g/mol,2.5,2.8,
214,dalfampridine (4-aminopyridine),C1=CN=CC=C1N,94.1164 g/mol,,,
215,gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,477.599 g/mol,,,
216,disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,339.48 g/mol,,,
217,domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,425.918 g/mol,3.96,7.89,
218,asciminib,C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,449.8432 g/mol,,3.93,1.24
219,apatinib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,493.5853 g/mol,,,
220,selexipag,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,496.62 g/mol,,,
221,pyrotinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/[C@H]5CCCN5C,583.1 g/mol,,,
222,tigecycline,CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,585.65 g/mol,0.8,,
223,vorapaxar,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C,492.5877 g/mol,,,
224,irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,586.685 g/mol,,,
227,telaprevir,CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5,679.8577 g/mol,4,,0.0047
228,vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,421.3026 g/mol,2.7,3.8,0.0001
229,duloxetine,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,297.42 g/mol,,,0.55
230,procyclidine,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O,287.444 g/mol,,,
232,maraviroc,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,513.67 g/mol,5.1,7.3,
233,lithium,[Li],6.941 g/mol,,,
234,oxaliplatin,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)[O-])[O-].[Pt+4],395.2728 g/mol,,,
235,darunavir,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,593.73 g/mol,,,
236,ibrutinib,C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,440.50 g/mol,3.97,3.74,0.003
237,deflazacort,CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C,441.517 g/mol,,,
238,tedizolid,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)CO)F,370.3425 g/mol,,,
239,clonazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,315.715 g/mol,,,
240,cabazitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,835.93 g/mol,,,
241,barnidipine,CC1=C([C@@H](C(=C(N1)C)C(=O)O[C@H]2CCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,491.541 g/mol,,,
242,lobeglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC,480.5426 g/mol,> 4.15,,
243,vilanterol,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl,774.8 g/mol,,,
244,alvimopan,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O,460.6 g/mol,,,
245,cefuroxime,CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O,424.388 g/mol,,,
246,GSK3179106,CCOC1=CC(=O)NC=C1C2=CC(=C(C=C2)CC(=O)NC3=NOC(=C3)C(C)(C)C(F)(F)F)F,467.4 g/mol,,,
247,ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N,404.4676 g/mol,,,
248,pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,185.23 g/mol,,,
249,nebivolol,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,405.44 g/mol,,8.5,
250,vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,488.61 g/mol,,,
251,mirodenafil,CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC,531.6743 g/mol,2.2,,
252,celiprolol,CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C,379.498 g/mol,,,
253,recainam,CC1=C(C(=CC=C1)C)NC(=O)NCCCNC(C)C,263.383 g/mol,,,
255,flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,276.2129 g/mol,,,
256,foscarnet,C(=O)(O)P(=O)(O)O,126.004 g/mol,,,
257,romidepsin,C/C=C\1/C(=O)N[C@H](C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C,540.7024 g/mol,,,
258,tegaserod,CCCCCN=C(N)N/N=C/C1=CNC2=C1C=C(C=C2)OC,417.47 g/mol,,,
259,Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,398.3976 g/mol,2.5,,
260,tamsulosin,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,408.516 g/mol,2.3,,
261,amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,408.879 g/mol,,8.6,0.55
262,isavuconazole,C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,437.4723 g/mol,3.5,,
263,alpelisib,CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,441.4758 g/mol,2.96,3.26,0.02
264,albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,265.336 g/mol,,,
265,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,179.305 g/mol,,,
266,montelukast,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,586.2 g/mol,7.7,4.3,
267,bremelanotide,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C,1025.1752 g/mol,,,
268,bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,348.483 g/mol,,,
269,ensartinib,C[C@@H]1CN(C[C@@H](N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)O[C@H](C)C4=C(C=CC(=C4Cl)F)Cl)N,561.4 g/mol,,,
270,ginsenoside Rb1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C,1109.2978 g/mol,,,
271,propiverine,CCCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OC3CCN(CC3)C,367.4861 g/mol,,,
272,carisbamate,C1=CC=C(C(=C1)[C@@H](COC(=O)N)O)Cl,215.635 g/mol,,,
273,mitragynine,CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,398.5 g/mol,,,
274,capivasertib,C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,428.9 g/mol,2.5241,6.15,
275,oteseconazole,C1=CC(=CC=C1C2=CN=C(C=C2)C([C@](CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OCC(F)(F)F,527.3984 g/mol,,,
277,gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,375.4 g/mol,,,
278,quinidine,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422 g/mol,,,
279,flupentixol,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,434.523 g/mol,,,
280,tenofovir disoproxil,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,519.445 g/mol,,,
281,inotersen,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=S)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=S)(O)O[C@H]4C[C@@H](O[C@@H]4COP(=S)(O)O[C@@H]5[C@H](O[C@H]([C@@H]5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)O[C@@H]8[C@H](O[C@H]([C@@H]8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,7183.08 g/mol,,,
282,entecavir,C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N,295.3 g/mol,,,
283,atorvastatin (acid),CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,558.6 g/mol,1.42,4.6,0.27
284,nateglinide,CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O,317.4 g/mol,3.2,,
285,aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,448.38 g/mol,,7.6,0.0055
286,cefixime,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O,453.454 g/mol,,,
287,losartan carboxylic acid,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)Cl,436.9009 g/mol,5,,
288,quizartinib,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,560.6758 g/mol,2.33,4.75,0.93
289,leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,270.209 g/mol,,,
290,dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,471.5 g/mol,,4,
291,docetaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,807.885 g/mol,,,
292,"(R,R)-labetalol (dilevalol)",C[C@H](CCC1=CC=CC=C1)NC[C@@H](C2=CC(=C(C=C2)O)C(=O)N)O,328.41 g/mol,,,
293,methoxyphenamine,CC(CC1=CC=CC=C1OC)NC,,2.6,10.45,
294,lacidipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C)C,455.548 g/mol,4.5,,
295,loperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,477.045 g/mol,5.5,9.41,
296,milnacipran,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2,246.35 g/mol,,,
297,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,284.425 g/mol,,,
298,ethinylestradiol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,296.408 g/mol,,10.33,0.00677
299,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,209.251 g/mol,,,
300,clorazepate,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O,314.727 g/mol,,,
301,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,575.683 g/mol,,,0.0055
302,bufuralol,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O,261.363 g/mol,,,
303,ritlecitinib,C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3,285.34 g/mol,,,31.85
304,mibefradil,CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F,495.635 g/mol,,,
306,nicergoline,CN1C[C@@H](C[C@]2([C@H]1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=CN=C5)Br,484.391 g/mol,3.3,,
307,droxidopa,C1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O,213.19 g/mol,,,
308,avosentan,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC=NC=C3)OC)OC4=CC=CC=C4OC,479.5149 g/mol,,,
309,levocabastine,C[C@@H]1CN(CC[C@@]1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,420.525 g/mol,,,
310,zimeldine,CN(C)C/C=C(/C1=CC=C(C=C1)Br)\C2=CN=CC=C2,,,,
312,dexmedetomidine,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C,200.28 g/mol,,,
313,sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,464.829 g/mol,,,
314,conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,498.583 g/mol,,,
,lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,628.809 g/mol,5.9,,
316,rasagiline,C#CCN[C@@H]1CCC2=CC=CC=C12,171.24 g/mol,,,
317,encainide,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC,352.4752 g/mol,,,
318,osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,596 g/mol,,4.4,0.6
319,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,344.4086 g/mol,,,
321,p-cresol,CC1=CC=C(C=C1)O,,,,
322,tanshinone IIA,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C,294.3 g/mol,,,0.055
323,BI 201335,CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)O[C@@H]4C[C@H](N(C4)C(=O)[C@H](C(C)(C)C)NC(=O)OC5CCCC5)C(=O)N[C@@]6(C[C@H]6C=C)C(=O)O,869.8 g/mol,,,
324,ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,427.54 g/mol,,7.2,
325,enfuvirtide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC7=CC=CC=C7)C(=O)NCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=C(C=C9)O)NNC(=O)C,4492 g/mol,,,
326,nefazodone,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,470.014 g/mol,4.3,,0.55
327,ursodeoxycholic acid (ursodiol),C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,392.576 g/mol,,,
328,solifenacin,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5,362.4704 g/mol,,,
329,laropiprant,CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CC[C@@H]3CC(=O)O)CC4=CC=C(C=C4)Cl)F,435.9 g/mol,,,
330,pacritinib,C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,472.5858 g/mol,3.8,,0.55
331,etonogestrel (3-keto-desogestrel),CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,324.5 g/mol,,,
332,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,160.179 g/mol,,,21.5
333,trabectedin,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,761.84 g/mol,,,
334,amsacrine,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,393.465 g/mol,,,
335,ipragliflozin,C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)F,404.4559 g/mol,3.38,,
336,octreotide,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O,1019.2 g/mol,,,
337,lamivudine,C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N,229.2589 g/mol,,,
338,solriamfetol,C1=CC=C(C=C1)C[C@H](COC(=O)N)N,194.2326 g/mol,,,
339,spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,416.579 g/mol,,,
340,AZD1305,CC(C)(C)OC(=O)NCCN1CC2CN(CC(C1)O2)CCOC3=C(C=C(C=C3)C#N)F,434.5089 g/mol,,9.9,
341,thioridazine,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,370.5824 g/mol,5.9,9.5,0.0000336
342,tofacitinib,C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,312.37 g/mol,1.15,5.07,2.9
343,sulfadoxine,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,310.3326 g/mol,,,
344,gabapentin,C1CCC(CC1)(CC(=O)O)CN,171.238 g/mol,,,
345,azilsartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,456.456 g/mol,2.5,2.5,0.0055
346,ribavirin,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,244.206 g/mol,,,
347,buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,385.509 g/mol,,,
348,cefetamet,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,397.435 g/mol,,,
349,lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,256.095 g/mol,,,
351,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,247.33 g/mol,,,
352,perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,277.492 g/mol,,,
353,itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,705.643 g/mol,5.66,,
354,haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,375.869 g/mol,,,0.01
356,terbinafine,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21,327.90 g/mol,,7.1,6.3
357,sulfaphenazole,C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N,314.4 g/mol,1.52,,1.5
358,tetracycline,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,444.4376 g/mol,,,
359,5-fluorouracil,C1=C(C(=O)NC(=O)N1)F,130.078 g/mol,,,
360,cilastatin,CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C,358.4564 g/mol,,,
362,triamterene,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,253.268 g/mol,,,
363,digitoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O,764.944 g/mol,,,
364,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,272.367 g/mol,,,
365,guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,282.55 g/mol,,,
366,mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,179.261 g/mol,,9.2,0.54
367,pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,461.5531 g/mol,,,
368,naproxen (S-naproxen),C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,230.2616 g/mol,,,
369,acebutolol,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,336.4 g/mol,,,
371,(S)-mephenytoin,CC[C@@]1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,218.2 g/mol,1.69,8.51,1.27
372,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,531.437 g/mol,4.3,,
373,quinine,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422 g/mol,,,
374,metformin,CN(C)C(=N)N=C(N)N,129.16 g/mol,-1.43,,
375,imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,280.413 g/mol,4.8,,
376,metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,267.366 g/mol,1.9,11.8,
378,nafcillin,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,414.4798 g/mol,2.9,,
379,tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,270.351 g/mol,2.34,5.16,109
380,vancomycin,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,1449.26 g/mol,,,
381,colchicine,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,399.44 g/mol,,12.8,21.5
382,ceftazidime,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],636.6 g/mol,,,
383,lisinopril,C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O,405.492 g/mol,,,
384,azapropazone,CCCC1C(=O)N2C3=C(C=CC(=C3)C)N=C(N2C1=O)N(C)C,300.36 g/mol,,,
385,nitrendipine,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,360.364 g/mol,2.4,,
386,trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,290.321 g/mol,,,
387,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,252.2718 g/mol,2.4,8.31,
388,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,180.166 g/mol,-0.02,8.81,7.36
390,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,454.445 g/mol,,,
391,vincristine,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,824.966 g/mol,,,
392,cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,252.34 g/mol,0.48,6.9,
393,flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,303.29 g/mol,,,
394,acitretin,CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C)C)C)OC,326.44 g/mol,,,
396,gallopamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC,484.633 g/mol,,,
397,ketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,395.4318 g/mol,,,
399,rifampin,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C,822.947 g/mol,,,0.055
400,amikacin,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,585.604 g/mol,,,
401,chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,318.87 g/mol,,,
403,bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,325.446 g/mol,,,
404,clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,314.858 g/mol,,,
406,timolol,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,316.42 g/mol,1.8,9.2,
408,doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,451.48 g/mol,,,
409,famotidine,C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N,337.43 g/mol,,,0.055
411,etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,287.357 g/mol,,,
412,isoniazid,C1=CN=CC=C1C(=O)NN,137.141 g/mol,,,
413,acetylsalicylic acid (aspirin),CC(=O)OC1=CC=CC=C1C(=O)O,180.1582 g/mol,,,
414,dronabinol (delta-(9)-tetrahydrocannabinol),CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,314.466 g/mol,6,10.6,
416,cannabidiol,CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,314.466 g/mol,,,
418,cefonicid,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O,542.572 g/mol,,,
419,ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,254.284 g/mol,,,
420,chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,274.79 g/mol,,,
421,tauroursodeoxycholic acid,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,499.7085 g/mol,,,5.5
422,methylnaltrexone,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,356.4394 g/mol,,,
423,fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,307.4747 g/mol,,,
424,tofogliflozin,CCC1=CC=C(C=C1)CC2=CC3=C(CO[C@@]34[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C2,386.4414 g/mol,,,
425,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,381.4 g/mol,,,
426,desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,310.8 g/mol,,,
427,(S)-methamphetamine (metamfetamine),C[C@@H](CC1=CC=CC=C1)NC,149.2355 g/mol,2.07,9.9,
428,dronedarone,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,556.764 g/mol,,,
429,ezogabine (retigabine),CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,303.335 g/mol,,3.7,0.045
430,telcagepant,C1C[C@H](C(=O)N(C[C@@H]1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5,566.5283 g/mol,,,
431,temafloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F,417.385 g/mol,,,
432,mipomersen,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])S[C@H]3C[C@@H](O[C@@H]3COP(=O)([O-])S[C@H]4C[C@@H](O[C@@H]4COP(=O)([O-])S[C@H]5C[C@@H](O[C@@H]5COP(=O)([O-])S[C@H]6C[C@@H](O[C@@H]6COP(=O)([O-])S[C@H]7C[C@@H](O[C@@H]7COP(=O)([O-])S[C@H]8C[C@@H](O[C@@H]8COP(=O)([O-])S[C@H]9C[C@@H](O[C@@H]9COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=NC2=C1N=C(NC2=O)N)CO)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)SP(=O)([O-])OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)SP(=O)([O-])OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=NC1=O)N)C)SP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)SP(=O)([O-])OC[C@H]1[C@@H]([C@@H]([C@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)SP(=O)([O-])OC[C@H]1[C@@H]([C@@H]([C@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)SP(=O)([O-])OC[C@H]1[C@@H]([C@@H]([C@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)SP(=O)([O-])OC[C@H]1[C@@H]([C@@H]([C@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,7594.9 g/mol,,,
433,ixazomib,B([C@H](CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,517.12 (ixazomib citrate) g/mol,,,
434,triclabendazole,CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,359.663 g/mol,,,0.1
435,luliconazole,C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl,354.28 g/mol,,,
436,grazoprevir,CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1,766.90 g/mol,,,0.0055
437,fidaxomicin,CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)OC(=O)C(C)C)O)O)\C)\C)[C@@H](C)O)\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\C,1058.04 g/mol,6.4,,0.55
438,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,239.744 g/mol,,,
439,diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,284.7447 g/mol,,,
443,crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,450.3 g/mol,4.28,9.4,
444,mebendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,295.297 g/mol,,,
445,lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,426.8581 g/mol,3.3,5.05,
446,sotrastaurin,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,438.4888 g/mol,,,
447,drospirenone,C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,366.498 g/mol,3.08,neutral,0.01646
448,"caffeine (1,3,7-TMX)",CN1C=NC2=C1C(=O)N(C(=O)N2C)C,194.1906 g/mol,,,
449,levomepromazine (methotrimeprazine),C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,328.478 g/mol,,,
451,caspofungin,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O,1093.32 g/mol,,,
452,dihydroartemisinin,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C,284.35 g/mol,,,
453,cinacalcet,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,357.417 g/mol,,,
454,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,410.49 g/mol,,,
456,nifurtimox,CC1CS(=O)(=O)CCN1/N=C/C2=CC=C(O2)[N+](=O)[O-],287.2947 g/mol,,,0.55
458,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,253.716 g/mol,1.72,7.49 (Base),
459,linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,337.35 g/mol,,,
460,liraglutide,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N)C(=O)O,3751.2355 g/mol,,,
461,tafenoquine,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,463.5 g/mol,,,
462,diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,296.152 g/mol,,,
464,xanomeline,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,281.42 g/mol,,,
465,tipiracil,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl,279.12 g/mol,,,
466,tacrolimus,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,804.024 g/mol,3.3,2.94,
467,linagliptin,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,472.5502 g/mol,1.7,8.6,0.9
468,ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F,522.5742 g/mol,,,0.016
469,daprodustat,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,393.4373 g/mol,5.28,3.24,0.208
470,oltipraz,CC1=C(SSC1=S)C2=NC=CN=C2,226.3 g/mol,,,
471,trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,266.3388 g/mol,,,
472,bromazepam,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3,316.157 g/mol,,,
474,monomethyl auristatin E,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC,717.9863 g/mol,,,
475,ulipristal,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,475.62 g/mol,,,
476,boceprevir,CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,519.6825 g/mol,3,,1.5
477,isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,371.391 g/mol,,,
478,zonisamide,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,212.23 g/mol,,,
479,"didanosine (2',3'-dideoxyinosine)",C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2N=CNC3=O,236.23 g/mol,,,
480,tacrine,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,198.268 g/mol,2.71,9.95,0.217
481,tazarotenic acid,CC1(CCSC2=C1C=C(C=C2)C#CC3=NC=C(C=C3)C(=O)O)C,323.414 g/mol,,,
483,artesunate,C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)O)C,384.4222 g/mol,,,
484,aprepitant,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,534.43 g/mol,4.8,,0.0055
486,ivosidenib,C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,582.96 g/mol,2.97,,0.0055
487,rifamycin,C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,697.7733 g/mol,,,
488,finasteride,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,372.549 g/mol,,,
489,baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,371.42 g/mol,,,
490,trospium,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,392.5 g/mol,,,
491,midecamycin acetate (miocamycin),CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)OC(=O)C)N(C)C)O)CC=O)C)OC(=O)C)C,898.046 g/mol,,,
492,sonidegib,C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,681.49 (phosphate form) g/mol,4.26,4.3,
495,cobimetinib,C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,531.3 g/mol,2.42,8.86,0.72
497,nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,539.6327; 649.76 (ethanesulfonate) g/mol,,,0.011
498,pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,356.444 g/mol,,,
499,ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,255.233 g/mol,,,
500,paclitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,853.913 g/mol,,,
501,ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl,436.8855 (free base); 566.00 (L-pyroglutamic acid form) g/mol,,,0.76
502,"L-771,688",COCC1=C([C@@H](N(C(=O)N1)C(=O)NCCCN2CCC(CC2)C3=CC=CC=N3)C4=CC(=C(C=C4)F)F)C(=O)OC,557.6 g/mol,2.4,,
503,carteolol,CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O,292.37 g/mol,,,
504,capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,359.352 g/mol,,,
505,dimethyl fumarate,COC(=O)/C=C/C(=O)OC,144.13 g/mol,,,
506,betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,307.43 g/mol,,,
507,levosimendan,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,280.2898 g/mol,,,
508,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,324.3969 g/mol,,9.5,5.5
509,efavirenz,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,315.68 g/mol,,,
510,omecamtiv mecarbil,CC1=NC=C(C=C1)NC(=O)NC2=CC=CC(=C2F)CN3CCN(CC3)C(=O)OC,401.4396 g/mol,,,
511,netivudine,CC#CC1=CN(C(=O)NC1=O)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,282.2506 g/mol,,,
512,diltiazem,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,414.523 g/mol,,,
513,dalfopristin,CCN(CC)CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@@H]([C@@H](/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)CC3=NC(=CO3)C2=O)O)/C)C)C(C)C,690.854 g/mol,,,
514,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,360.8 g/mol,,,
516,zolmitriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3,287.36 g/mol,,,
517,kanamycin,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,484.499 g/mol,,,
518,tenoxicam,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3,337.3789 g/mol,1.9,,0.0141
521,ginsenoside Rd,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,947.1578 g/mol,,,
522,vinorelbine,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,778.942 g/mol,,,
523,rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.34 g/mol,,,
524,vilazodone,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,441.5323 g/mol,,7.1,0.32
525,oseltamivir acid,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)O,284.3536 g/mol,,,
526,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,152.181 g/mol,,,
528,pramipexole,CCCN[C@H]1CCC2=C(C1)SC(=N2)N,211.33 g/mol,,,
530,mitiperstat,C[C@H](C1=C(C=CC(=C1)Cl)CN2C3=C(C(=O)NC2=S)NC=C3)N,334.8 g/mol,,,
531,lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,293.724 g/mol,,,
532,exemestane,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,296.41 g/mol,3.1,,
533,zuclopenthixol,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,400.971 g/mol,,,
534,lurasidone,C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O,492.6844 g/mol,5.4,1.96,
535,ezetimibe,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O,409.43 g/mol,,,
536,sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,666.7 g/mol,,,
537,talviraline,CC(C)OC(=O)N1[C@H](C(=S)NC2=C1C=C(C=C2)OC)CSC,340.466 g/mol,2.7,,
538,tilidine,CCOC(=O)[C@@]1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2,273.3737 g/mol,,,
539,tetrabenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,317.4 g/mol,,,
540,streptomycin,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,581.574 g/mol,,,
541,rifabutin,C[C@H]1/C=C/C=C(\C(=O)N=C2C(=C3C(=C4C2=NC5(N4)CCN(CC5)CC(C)C)C6=C(C(=C3O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)O)/C,847.013 g/mol,3.2,,0.19
542,fimasartan,CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C,501.6559 g/mol,,,
543,neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,557.0511 g/mol,4.9,7.65,
544,stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,224.2148 g/mol,,,
546,fludarabine,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,365.2 g/mol,,,
547,asunaprevir,CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,748.3 g/mol,,,
548,valacyclovir (L-valacyclovir),CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,324.339 g/mol,,,
549,tasimelteon,CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2,245.3201 g/mol,2.43,,1.1
550,mirabegron,C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,396.5126 g/mol,2.1,,
551,tolterodine,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,325.493 g/mol,1.83,9.87,12
552,alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,389.4 g/mol,,,
554,treprostinil,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,412.49 (Na) g/mol,,,
555,eliglustat,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O,404.5474 (free base) g/mol,2.84,8.79,
556,eplerenone,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,414.5 g/mol,7.1,,0.55
557,selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,457.6855 g/mol,,2.8,0.55
558,mavorixafor,C1C[C@@H](C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3,349.4793 g/mol,2.4,11.5,3.3
559,alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,330.8 g/mol,,6.95,
562,sulfamethizole,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,270.3 g/mol,0.54,2.1,1.05
563,"arformoterol (R,R-formoterol)",C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O,344.4086 g/mol,,,
564,tocainide,CC1=C(C(=CC=C1)C)NC(=O)C(C)N,192.26 g/mol,,,
565,telithromycin,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,812.0115 g/mol,3,,0.3
566,morphothiadin,CCOC(=O)C1=C(NC(=NC1C2=C(C=C(C=C2)F)Br)C3=NC=CS3)CN4CCOCC4,509.4 g/mol,2.5,,
567,itopride,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC,358.4354 g/mol,,,
568,safinamide,C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,302.3471 g/mol,,,0.27
570,flurbiprofen,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,244.264 g/mol,,,
571,relebactam,C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3,348.378 g/mol,,,
572,tasisulam,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,415.1144 g/mol,,,
574,artemisinin,C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,282.334 g/mol,,,
575,indoxyl sulfate,C1=CC=C2C(=C1)C(=CN2)OS(=O)(=O)O,213.212 g/mol,,,
576,aplaviroc,CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O,577.7177 g/mol,,,
577,zileuton,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,236.29 g/mol,,,0.0055
578,sertraline,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,306.234 g/mol,,,
579,osilodrostat,C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F,227.241 g/mol,,6.9,
580,gemcitabine,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,263.1989 g/mol,,,
581,nortilidine,CCOC(=O)[C@]1(CCC=C[C@@H]1NC)C2=CC=CC=C2,259.34 g/mol,,,
582,eprosartan,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O,424.519 g/mol,,,
584,bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,530.446 g/mol,,,
585,argatroban,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,526.66 g/mol,,,
586,acyclovir,C1=NC2=C(N1COCCO)N=C(NC2=O)N,225.207 g/mol,,,
589,macitentan,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,588.279 g/mol,3.7,,
590,quinupristin,CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C,1022.2313 g/mol,,,
591,clozapine,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,326.829 g/mol,,,
592,nusinersen,CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=S)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=C(C(=NC4=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=NC7=C(N=CN=C76)N)OCCOC)OP(=S)(O)OC[C@@H]8[C@H]([C@H]([C@@H](O8)N9C=C(C(=NC9=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)O)OCCOC,7501.0 g/mol,,,
594,(R)-omeprazole,CC1=CN=C(C(=C1OC)C)C[S@@](=O)C2=NC3=C(N2)C=C(C=C3)OC,345.4 g/mol,,9.29,0.36
595,triamcinolone,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,394.4 g/mol,,,
596,nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O,309.403 g/mol,,,
597,ethosuximide,CCC1(CC(=O)NC1=O)C,141.169 g/mol,,,
598,S-3304,CC1=CC=C(C=C1)C#CC2=CC=C(S2)S(=O)(=O)N[C@H](CC3=CNC4=CC=CC=C43)C(=O)O,464.564 g/mol,,,
599,seliciclib (R-roscovitine),CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,354.455 g/mol,,,
600,phenprocoumon,CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,280.3 g/mol,3.62,4.1,
601,TAK-272,CC(C)CN([C@H]1C[C@H](CNC1)C(=O)N2CCOCC2)C(=O)C3=NC4=CC=CC=C4N3CCCCOC.Cl,536.1128 g/mol,,,
602,remacemide,CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN,268.358 g/mol,,,
603,quinapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O,438.521 g/mol,,,
604,dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4,487.95 g/mol,,,
605,empagliflozin,C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl,450.91 g/mol,,,0.55
606,naldemedine,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C([C@H]4[C@@]56CCN([C@@H]([C@@]5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,570.6426 (free base); 742.84 (tosylate) g/mol,3.2,,
607,isosorbide dinitrate,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O[N+](=O)[O-])O[N+](=O)[O-],236.135 g/mol,,,
608,quazepam,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,386.799 g/mol,,,
609,bedaquiline,CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O,555.50 g/mol,,,
610,fluvastatin (acid),CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,411.47 g/mol,,,101
611,tiopronin,CC(C(=O)NCC(=O)O)S,163.196 g/mol,,,
613,buprenorphine,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O,467.646 g/mol,4.82,,
615,arbutin,C1=CC(=CC=C1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,272 g/mol,-1.1,,
616,tirilazad,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@H]1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C,624.8599 g/mol,,,
617,fluticasone,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)O)C)O)F)C)F,444.511 g/mol,,,
618,temazepam (3-hydroxydiazepam),CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,300.744 g/mol,,,
619,dotinurad,C1N(C2=CC=CC=C2S1(=O)=O)C(=O)C3=CC(=C(C(=C3)Cl)O)Cl,358.2001 g/mol,,,
621,acalabrutinib,CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,465.5147 g/mol,,,
622,filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,425.5107 g/mol,,,
623,aliskiren,CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,551.7637 g/mol,,,
624,vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,264.32 g/mol,,,
625,teriparatide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N,4117.8 g/mol,,,
626,anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,293.372 g/mol,,,
627,velpatasvir,C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC,883.0136 g/mol,,,
628,benznidazole,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],260.2518 g/mol,,,
629,netupitant and palonosetron,C/C=C(/C=C)\C1=CC(=NC=C1N(C)C(=O)C(C)(C)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)N3CCN(CC3)C.C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5,"578.61 (netupitant), 332.87 (palonosetron) g/mol",,,
630,setrobuvir,CS(=O)(=O)NC1=CC2=C(C=C1)NC(=NS2(=O)=O)C3=C([C@@H]4[C@H]5CC[C@H](C5)[C@@H]4N(C3=O)CC6=CC=C(C=C6)F)O,560.6245 g/mol,,,
632,glipizide,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,445.541 g/mol,,5.9,
633,elbasvir and grazoprevir,CC(C)[C@@H](C(=O)N1CCC[C@@H]1C2N=CC(=N2)C3=CC4=C(C=C3)C5=CC6=C(N5[C@@H](O4)C7=CC=CC=C7)C=CC(=C6)C8=CN=C(N8)[C@@H]9CCCN9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1,elbasvir: 882.02; grazoprevir: 766.90 g/mol,,,0.0055
634,brivaracetam,CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N,212.291 g/mol,,,
635,fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,411.5823 g/mol,,,
636,levofloxacin,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,361.371 g/mol,,,
638,levonorgestrel,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,312.4 g/mol,,,
639,atazanavir,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,704.864 g/mol,,4.7,
640,lorlatinib,C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,406.41 g/mol,2.47,,
641,prucalopride,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,367.8744 g/mol,,,
642,fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,437.527 g/mol,,,
643,olmesartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,558.59 g/mol,,,
644,azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,381.905 g/mol,,,
645,peramivir,CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C,382.45 g/mol,,,
646,esketamine,CN[C@@]1(CCCCC1=O)C2=CC=CC=C2Cl,237.728 g/mol,,,
647,rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl,435.8862 g/mol,,,
648,iomeprol,CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,777.09 g/mol,,,
649,azithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,748.989 g/mol,,8.1,100
650,desirudin,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H]2C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)[C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCCCN)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC7=CN=CN7)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC8=CC=CC=C8)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N9CCC[C@H]9C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C,6963.48 g/mol,,,
651,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,305.34 g/mol,1.3,,
654,dalbavancin,CC(C)CCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)NC(C7=C(C(=CC(=C7)O)O[C@@H]8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C9=C(C=CC(=C9)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)[C@H](C(=O)N[C@H](CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O,1816.71 g/mol,,,
655,axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,386.4772 g/mol,3.5,4.8,0.0002
656,nafithromycin,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)[C@@H](C(=O)O2)/C(=N/O[C@@H](C)C4=NN=C(S4)C5=CC=CC=N5)/N)C,859.0488 g/mol,,,
657,rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,323.3692 g/mol,,,1.7
658,N-desmethylimatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCNCC3)NC4=NC=CC(=N4)C5=CN=CC=C5,479.6 g/mol,,,
659,tapentadol,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,221.34 (free base) g/mol,2.87,9.34,
660,galantamine,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O,287.357 g/mol,,,
661,erythromycylamine,CC[C@@H]1[C@@]([C@@H]([C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)N)C)O)(C)O,735.0 g/mol,,,
662,ambrisentan,CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,378.42 g/mol,,,
663,deferiprone,CC1=C(C(=O)C=CN1C)O,139.15 g/mol,0.23,3.23,
665,oxycodone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,315.367 g/mol,0.7,8.53,154.8
666,vilaprisan,C[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C(C(F)(F)F)(F)F)O)C5=CC=C(C=C5)S(=O)(=O)C,544.5781 g/mol,,,0.0005
668,pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,597.49 g/mol,,,
669,DNDI-VL-2098,C[C@@]1(CN2C=C(N=C2O1)[N+](=O)[O-])COC3=CC=C(C=C3)OC(F)(F)F,359.26 g/mol,,,
670,carfilzomib,CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,719.9183 g/mol,,,0.0055
671,rolapitant,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC[C@]2(CC[C@]3(CCC(=O)N3)CN2)C4=CC=CC=C4,500.48 g/mol,,,
672,erythromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,733.93 g/mol,,,0.55
676,pindolol,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,248.32 g/mol,,,
677,amiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,645.31 g/mol,,,
678,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,384.257 g/mol,,5.07,
680,alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,308.771 g/mol,,,
681,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,378.31 g/mol,,,
682,imipenem,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,299.3493 g/mol,,,
684,alprenolol,CC(C)NCC(COC1=CC=CC=C1CC=C)O,249.352 g/mol,,,
686,methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,309.45 g/mol,,9.2,
688,chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,319.877 g/mol,,,
690,temocillin,CC1([C@@H](N2[C@H](S1)[C@@](C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,414.4572 g/mol,,,
691,pentazocine,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O,285.4283 g/mol,3.31,8.5,
692,cephalexin,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O,347.393 g/mol,,,
693,nizatidine,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C,331.463 g/mol,,,
695,cefotetan,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O,575.6263 g/mol,,,
696,piperacillin,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,517.56 g/mol,,,
697,sulfinpyrazone,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4,404.5 g/mol,2.3,3.25,0.0312
698,flucloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,453.8763 g/mol,,,
703,gestodene,CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,310.4 g/mol,,,
704,prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,383.406 g/mol,,,
705,amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,277.409 g/mol,,,
706,procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,235.329 g/mol,,,
707,carumonam,C1=C(N=C(S1)N)/C(=N/OCC(=O)O)/C(=O)N[C@H]2[C@H](N(C2=O)S(=O)(=O)O)COC(=O)N,466.4066 g/mol,,,
708,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,233.309 g/mol,,,
709,esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,295.37 g/mol,,,
710,piroxicam,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,331.3 g/mol,,,
711,etoposide,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,588.559 g/mol,,,
713,chlormethiazole,CC1=C(SC=N1)CCCl,161.6552 g/mol,,,
715,codeine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,299.368 g/mol,,,
716,aztreonam,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N,435.44 g/mol,,,
718,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,294.4394 g/mol,,,0.055
719,norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,319.334 g/mol,-1.03,6.34,0.055
721,isotretinoin (13-cis-retinoic acid),CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C,300.44 g/mol,,,
723,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,285.36 g/mol,,,0.06
724,phenacetin,CCOC1=CC=C(C=C1)NC(=O)C,179.22 g/mol,,,
725,fluvoxamine,COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F,318.337 g/mol,3.38,9.16,0.06
728,warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,308.331 g/mol,,5.1,
729,diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,255.36 g/mol,,,
733,lovastatin (lactone),CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,404.543 g/mol,4.08,13.49,
734,oxprenolol,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,265.351 g/mol,,,
736,phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,232.2 g/mol,,,
737,flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,414.344 g/mol,,,
738,ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,263.791 g/mol,2.9,,
739,felbamate,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,238.242 g/mol,,,
740,cefotaxime,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,455.47 g/mol,,,
741,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],171.155 g/mol,,,
742,cyclosporine,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1202.62 g/mol,,,
744,tretinoin (all-trans-retinoic acid),CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,300.44 g/mol,,,
746,amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,229.63 g/mol,,,
747,oseltamivir,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC,312.407 g/mol,,,
748,triclabendazole sulfone,CS(=O)(=O)C1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,391.7 g/mol,,,
749,tivozanib,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,454.8681 g/mol,4.09,5.9,0.09
750,benperidol,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,381.449 g/mol,,,
752,regorafenib N-oxide (M2),CNC(=O)C1=[N+](C=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F)[O-],498.8 g/mol,,,
754,bortezomib,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,384.241 g/mol,,,
755,paynantheine,CO/C=C(\[C@H]1C[C@H]2C3=C(CCN2C[C@@H]1C=C)C4=C(N3)C=CC=C4OC)/C(=O)OC,396.4794 g/mol,,,
756,cefdinir,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\O)/C3=CSC(=N3)N)SC1)C(=O)O,395.419 g/mol,,,
757,zanamivir,CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N,332.31 g/mol,,,
758,apinocaltamide,C1CC1(C2=CC=C(C=C2)CC(=O)NC3=NN(C=C3)CC4=NC=C(C=C4)C#N)C(F)(F)F,425.4 g/mol,,,
759,darifenacin,C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,426.557 g/mol,,,
760,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,369.366 g/mol,2.8,1.1,
762,dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,504.632 g/mol,,,
763,daridorexant,CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl,450.9207 g/mol,3.9,,
764,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,269.35 g/mol,,,
765,alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,482.62 g/mol,,,
766,blonanserin,CCN1CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F,367.509 g/mol,,,
768,brecanavir,CC1=NC(=CS1)COC2=CC=C(C=C2)C[C@@H]([C@@H](CN(CC(C)C)S(=O)(=O)C3=CC4=C(C=C3)OCO4)O)NC(=O)O[C@H]5CO[C@@H]6[C@H]5CCO6,703.83 g/mol,,,
769,fexinidazole,CN1C(=CN=C1COC2=CC=C(C=C2)SC)[N+](=O)[O-],279.3187 g/mol,,1.8,0.55
770,donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,379.497 g/mol,,,
771,3-carboxy-4-methyl-5-propyl-2-furanpropionate,CCCC1=C(C(=C(O1)CCC(=O)O)C(=O)O)C,240.25 g/mol,,,
772,(R)-bicalutamide,C[C@](CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,430.37 g/mol,,,
773,lomitapide,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,693.7283 g/mol,8.6,8.2,21.5
774,lorcaserin,C[C@H]1CNCCC2=C1C=C(C=C2)Cl,195.6916 g/mol,2.56,9.53,418
775,polymyxin B,CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)[C@@H](C)O,2392.9516 g/mol,,,
776,lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,581.065 g/mol,5.1,3.8,
780,baloxavir,C1COC[C@@H]2N1C(=O)C3=C(C(=O)C=CN3N2[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F)O,483.5 g/mol,,,
781,ledipasvir,CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,889.0116 g/mol,7.4,4,
782,tiotropium,C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,392.5178 g/mol,,,
783,tafamidis,C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl,308.1193 g/mol,,,
784,sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,253.281 g/mol,0.795,1.6,0.0055
785,olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,312.44 g/mol,,4.69,0.0046
786,alisporivir,CC[C@H]1C(=O)N([C@@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,1216.6507 g/mol,,,
787,amphotericin B,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,924.084 g/mol,,,
788,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],273.243 g/mol,,,
789,leniolisib,CCC(=O)N1CC[C@@H](C1)NC2=NC=NC3=C2CN(CC3)C4=CC(=C(N=C4)OC)C(F)(F)F,450.4625 g/mol,2.5,,
790,vaborbactam,B1([C@H](CC[C@H](O1)CC(=O)O)NC(=O)CC2=CC=CS2)O,297.14 g/mol,,,
791,tanespimycin,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,585.6937 g/mol,,,
792,vonoprazan,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3,345.40 g/mol,2.74,9.3,0.55
793,AFN-1252,CC1=C(OC2=CC=CC=C12)CN(C)C(=O)/C=C/C3=CC4=C(NC(=O)CC4)N=C3,375.4259 g/mol,,,
794,istradefylline,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C,384.4336 g/mol,2.5,7.8,0.0006
795,mavacamten,C[C@@H](C1=CC=CC=C1)NC2=CC(=O)N(C(=O)N2)C(C)C,273.3341 g/mol,,,0.0055
796,(R)-cetirizine (levocetirizine),C1CN(CCN1CCOCC(=O)O)[C@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl,388.892 g/mol,,,
797,paroxetine,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,329.369 g/mol,2.53,9.51,
798,selegiline,C[C@H](CC1=CC=CC=C1)N(C)CC#C,187.28 g/mol,2.7,7.44,3.8
799,pibrentasvir,C[C@H]([C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C(=C3)F)[C@H]4CC[C@@H](N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)OC)NC(=O)OC)NC(=O)OC)OC,1113.18 g/mol,,,0.0055
800,pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,273.2469 g/mol,,,
801,suvorexant,C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,450.9277 g/mol,,,
802,moxidectin,C[C@@H]\1C/C(=C/C[C@@H]2C[C@@H](C[C@@]3(O2)C/C(=N\OC)/[C@@H]([C@H](O3)/C(=C/C(C)C)/C)C)OC(=O)[C@@H]4C=C([C@H]([C@@H]5[C@]4(/C(=C/C=C1)/CO5)O)O)C)/C,639.825 g/mol,,,
804,feprazone,CC(=CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)C,320.39 g/mol,,5.1,
806,glycoobeticholic acid,CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)NCC(=O)O)C)C)O,477.6765 g/mol,,,
807,dihydroergotamine,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C,583.685 g/mol,,,
808,vamorolone,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@]1(C(=O)CO)O)C)C,356.46 g/mol,4.39,,
809,niraparib,C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,320.394 g/mol,,,
813,dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl,408.87 g/mol,,,
814,papaverine,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,339.389 g/mol,,,
815,acamprosate,CC(=O)NCCCS(=O)(=O)O,181.211 g/mol,,,
816,itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,553.5217 g/mol,1.6,,
817,AZD1981,CC1=C(C2=C(C=CC=C2N1CC(=O)O)NC(=O)C)SC3=CC=C(C=C3)Cl,388.8733 g/mol,,,
818,tozasertib,CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C,464.5952 g/mol,,,
819,danusertib,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)[C@@H](C5=CC=CC=C5)OC,474.562 g/mol,,,
820,methylarbutin,COC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,286.278 g/mol,-0.7,,
821,azilsartan medoxomil,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)OCC6=C(OC(=O)O6)C,568.5396 g/mol,,,0.0055
822,p-aminosalicylate,C1=CC(=C(C=C1N)[O-])C(=O)O,153.135 g/mol,,,
823,deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,373.4 g/mol,,,
824,hydroxyurea,C(=O)(N)NO,76.0546 g/mol,,,
825,hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,297.742 g/mol,,,
827,dexlansoprazole,CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,369.366 g/mol,,,0.16
829,glecaprevir and pibrentasvir,C[C@H]([C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C(=C3)F)[C@H]4CC[C@@H](N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)OC)NC(=O)OC)NC(=O)OC)OC.CC1(CC1)S(=O)(=O)NC(=O)[C@]2(C[C@H]2C(F)F)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)O[C@@H]5CCC[C@H]5OC/C=C/C(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,838.87 g/mol,,,
831,ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,467.42 g/mol,4.53,6.31,
834,finerenone,CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C,378.4298 g/mol,,4.3,
838,amenamevir,CC1=C(C(=CC=C1)C)N(CC(=O)NC2=CC=C(C=C2)C3=NOC=N3)C(=O)C4CCS(=O)(=O)CC4,482.5584 g/mol,,,
840,nefopam,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3,253.3431 g/mol,,,
841,abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,506.59 g/mol,,,
842,sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,398.4793 g/mol,5.2,8.95,
843,bromfenac,C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O,334.16 g/mol,,,
844,didesmethylcitalopram,C1C2=C(C=CC(=C2)C#N)C(O1)(CCCN)C3=CC=C(C=C3)F,296.3 g/mol,,,
845,febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,316.379 g/mol,,,0.0055
846,rifapentine,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C,877.031 g/mol,,,
847,tenofovir,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,287.2146 g/mol,,,
848,enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,464.4414 g/mol,2.98,,0.002
849,indisulam,C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=C(C=C3)S(=O)(=O)N)NC=C2Cl,385.851 g/mol,,,
850,dasabuvir,CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O,493.5813 g/mol,,,
851,tadalafil,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,389.41 g/mol,2.89,,
852,tinidazole,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,247.274 g/mol,,,
853,orlistat,CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,495.75 g/mol,,,
856,momelotinib,C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N,414.4668 g/mol,2.96,1.4,0.002
857,bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,551.621 g/mol,1.3,5.46,
860,toremifene,CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3,405.966 g/mol,,,
862,doxapram,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,378.513 g/mol,,,
863,plazomicin,C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CNCCO)N)N)NC(=O)[C@H](CCN)O)O,592.6862 g/mol,,,
864,amphetamine,CC(CC1=CC=CC=C1)N,135.21 g/mol,1.8,9.9,
865,umeclidinium,C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5,428.5926 g/mol,,,
866,paritaprevir,CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,765.8877 g/mol,,,
867,raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,444.42 g/mol,,,
868,nilvadipine,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,385.374 g/mol,,,
870,nelfinavir,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O,567.79 g/mol,5.7,,0.55
871,aprocitentan,C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br,546.1986 g/mol,,,0.0055
872,artemether,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,298.376 g/mol,,,0.0055
873,varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,361.35 g/mol,,,
874,amifampridine,C1=CN=CC(=C1N)N,109.131 g/mol,,,
875,elagolix,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,631.595 g/mol,1.8,4,
876,fedratinib,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,524.6864 g/mol,,6.3,0.004
877,ipratropium,CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C,332.461 g/mol,,,
878,fostamatinib,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,580.46 g/mol,,4.2,
879,cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,369.46 g/mol,,,
880,nabumetone,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,228.289 g/mol,,,
881,miglitol,C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O,207.2 g/mol,,,
882,pretomanid,C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,359.2588 g/mol,,,0.01
883,thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,258.232 g/mol,,,0.055
884,fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,309.33 g/mol,,,
885,granisetron,CN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,312.4 g/mol,,,
886,rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,359.4479 g/mol,,,
887,ravtansine,C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)C)\C)OC)(NC(=O)O2)O,780.4 g/mol,,,
889,lonafarnib,C1CN(CCC1CC(=O)N2CCC(CC2)[C@@H]3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,638.829 g/mol,4.7,2.8,0.0055
890,treosulfan,CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,278.3 g/mol,,,70
891,oxcarbazepine,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,252.3 g/mol,1.31,10.7,
892,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,288.432 g/mol,,,
893,brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,584.1011 g/mol,,,3
894,ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,261.087 g/mol,,,
895,ixabepilone,C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C,506.7 g/mol,,,
897,palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,447.54 g/mol,0.99,7.4,
898,tofisopam,CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C,382.5 g/mol,,,
899,keto-darolutamide,C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=CC(=NN3)C(=O)C,396.8 g/mol,,,
901,glasdegib,CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,374.4458 g/mol,,1.7,1.7
902,fidaxomicin metabolite OP-1118,CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)O)O)O)\C)\C)[C@@H](C)O)\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\C,987.9 g/mol,4.8,,
905,azimilide,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)/N=C/C3=CC=C(O3)C4=CC=C(C=C4)Cl,457.959 g/mol,,,
907,sitafloxacin,C1CC12CN(C[C@H]2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)[C@@H]5C[C@@H]5F)F,409.818 g/mol,,,
908,zoledronic acid,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,290.1 g/mol,,,
909,risdiplam,CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6,401.4717 g/mol,,,
911,imetelstat,CCCCCCCCCCCCCCCC(=O)NCC(COP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(=O)NC2=O)C)NP(=S)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C(N=CN=C54)N)NP(=S)(O)OC[C@@H]6[C@H](C[C@@H](O6)N7C=NC8=C7N=C(NC8=O)N)NP(=S)(O)OC[C@@H]9[C@H](C[C@@H](O9)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=CC(=NC1=O)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)NP(=O)(OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)N)S)O,4610.2379 g/mol,,,
912,riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,234.2005 g/mol,,,
913,dolutegravir,C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,419.3821 g/mol,,,
915,insulin degludec,CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N[C@@H](CC7=CC=C(C=C7)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N8CCC[C@H]8C(=O)N[C@@H](CCCCNC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCC(=O)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CO)[C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CN,6103.97 g/mol,,,
916,amoxicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C,365.408 g/mol,,,
917,grepafloxacin,CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F,359.399 g/mol,,,
918,pasireotide,C1[C@H](CN2[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,1047.206 g/mol,,10.2,
919,pilsicainide,CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3,308.85 g/mol,,,
920,losigamone,COC1=CC(=O)OC1C(C2=CC=CC=C2Cl)O,254.668 g/mol,,,
921,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,440.461 g/mol,,,
922,revexepride,CC1(CC2=C(O1)C(=CC(=C2N)Cl)C(=O)NC[C@@H]3CCN(C[C@H]3O)CCCOC)C,425.9538 g/mol,,,
923,elvitegravir,CC(C)[C@@H](CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O,447.8877 g/mol,,,
924,telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,514.63 g/mol,7.7,,
925,mycophenolic acid,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O,320.339 g/mol,,,
926,morphine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,285.341 g/mol,,,
927,anidulafungin,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O,1140.3 g/mol,,,
928,ruxolitinib,C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,306.4 g/mol,2.814,4.3 and 11.8,0.15
929,daidzein,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O,254.24 g/mol,,,
932,abiraterone,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O,349.5 g/mol,,,
933,pyrazinamide,C1=CN=C(C=N1)C(=O)N,123.115 g/mol,-0.6,-0.5,15000
935,semagacestat,C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2CCN(C1=O)C)NC(=O)[C@H](C(C)C)O,361.4393 g/mol,,,
936,cilomilast,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,343.4 g/mol,,,
937,dexloxiglumide,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl,461.383 g/mol,,,
938,eribulin,C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O,729.9 g/mol,,,
940,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,294.744 g/mol,,,
942,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,260.3786 g/mol,,,
946,roxithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,837.05 g/mol,,,
948,frovatriptan,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,243.308 g/mol,,,
949,semaxinib,CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C,238.289 g/mol,,,
950,samidorphan,C1CC1CN2CC[C@]34CC(=O)CC[C@]3([C@H]2CC5=C4C(=C(C=C5)C(=O)N)O)O,370.4 g/mol,2.4,8.3,
953,pregabalin,CC(C)C[C@@H](CC(=O)O)CN,159.227 g/mol,,,
954,vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,475.3596 g/mol,,5.2,0.008
955,edaravone (norantipyrine),CC1=NN(C(=O)C1)C2=CC=CC=C2,174.202 g/mol,,,
956,methylprednisolone,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,374.474 g/mol,1.9,,
957,eletriptan,CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,382.525 g/mol,,,
959,givosiran,C[C@@H]1C[C@H](CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCO[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)NC(=O)C)O,16300.34 g/mol,,,
960,fevipiprant,CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O,426.4133 g/mol,,,
962,avitriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC,458.584 g/mol,,,
963,panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO,349.43 g/mol,,,4.775
964,betulin,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)CO,442.7 g/mol,,,
965,netupitant,CC1=CC=CC=C1C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C,578.6 g/mol,,,
966,gemifloxacin,CO/N=C/1\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,389.385 g/mol,,,
967,oxypurinol,C1=NNC2=C1C(=O)NC(=O)N2,152.1126 g/mol,,,
968,armodafinil (R-modafinil),C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N,273.354 g/mol,,,
969,lornoxicam,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,371.824 g/mol,,,
970,daptomycin,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]3[C@H](OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)[C@H](C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,1620.68 g/mol,,,
971,indole-3-acetic acid,C1=CC=C2C(=C1)C(=CN2)CC(=O)O,175.18 g/mol,,,
972,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,330.75 g/mol,,3.9,0.0055
984,propafenone,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,341.448 g/mol,,8.8,0.55
985,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,416.134 g/mol,5.3,,
987,ceforanide,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O,519.5609 g/mol,,,
991,digoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,780.943 g/mol,,,
996,aminoglutethimide,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,232.281 g/mol,,,0.55
1004,omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,345.42 g/mol,,,
1007,opicapone,CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-],413.172 g/mol,,,0.55
1008,risedronate,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,305.10 g/mol,,,
1009,astemizole,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,458.578 g/mol,,,
1010,trovafloxacin,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,416.358 g/mol,,,
1012,desmethylcitalopram,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,310.4 g/mol,,,
1013,atovaquone,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,366.8 g/mol,,,
1014,ezetimibe glucuronide,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,585.5 g/mol,,,
1015,fenebrutinib,C[C@H]1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,664.8066 g/mol,3.3,5,
1016,hydromorphone,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4,285.341 g/mol,,,
1017,silodosin,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,495.53 g/mol,,,
1018,olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,434.46 g/mol,1.49,-1.25,
1019,talinolol,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,363.499 g/mol,2.89,,
1020,atomoxetine,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,291.82 g/mol,,,27.8
1023,acenocoumarol,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O,353.3285 g/mol,,,
1024,epirubicin,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,543.522 g/mol,,,
1026,lumefantrine,CCCCN(CCCC)CC(C1=CC(=CC\2=C1C3=C(/C2=C/C4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,528.9478 g/mol,8.7,,
1027,cefuroxime axetil,CC(OC(=O)C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CC=CO3)COC(=O)N,510.5 g/mol,,,
1028,delavirdine,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,456.568 g/mol,,,
1029,penbutolol,CC(C)(C)NC[C@@H](COC1=CC=CC=C1C2CCCC2)O,291.432 g/mol,,,
1031,ulifloxacin,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCNCC4,349.379943 g/mol,,,
1032,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,293.32 g/mol,,,
1033,peficitinib,C1[C@@H]2CC3(C[C@@H](C2NC4=C5C=CNC5=NC=C4C(=O)N)CC1C3)O,326.3978 g/mol,,,0.055
1035,topotecan,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,421.451 g/mol,,,
1037,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,273.354 g/mol,1.7,,
1041,O(6)-benzylguanine,C1=CC=C(C=C1)COC2=NC(=NC3=C2NC=N3)N,241.253 g/mol,,9.35,
1043,asenapine,CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,285.7724 g/mol,,8.6,3.7
1044,torsemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,348.425 g/mol,,7.1,
1045,manidipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,610.7072 g/mol,5.18,,
1046,AZD5069,C[C@H]([C@H](CO)O)OC1=NC(=NC(=C1)NS(=O)(=O)N2CCC2)SCC3=C(C(=CC=C3)F)F,476.5179 g/mol,,,
1047,roxadustat,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,352.3444 g/mol,,,
1048,fusidic acid,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\C(=O)O)OC(=O)C)C)O)C,516.714 g/mol,,,
1049,canagliflozin,CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,444.5205 g/mol,,,
1051,rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,314.36 g/mol,,,
1052,(S)-cetirizine,C1CN(CCN1CCOCC(=O)O)[C@@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl,388.9 g/mol,,,
1053,ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,293.37 g/mol,,,
1054,levorphanol,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O,257.375 g/mol,,,
1055,fulvestrant,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,606.8 g/mol,,,
1056,siponimod,CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O,516.6005 g/mol,,,
1057,dinaciclib,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO,396.4922 g/mol,,,
1058,cocaine,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,303.35 g/mol,,,
1059,alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,249.096 g/mol,,,
1060,thiopental,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC,242.34 g/mol,,,
1061,escitalopram,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,324.3969 g/mol,,,
1063,glecaprevir,CC1(CC1)S(=O)(=O)NC(=O)[C@]2(C[C@H]2C(F)F)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)O[C@@H]5CCC[C@H]5OC/C=C/C(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,838.87 g/mol,,,
1064,erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,393.441 g/mol,,,
1066,eszopiclone,CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,388.8133 g/mol,,,
1067,carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,406.479 g/mol,4.19,7.47,
1068,elbasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC4=C(C=C3)N5[C@@H](OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)[C@@H]8CCCN8C(=O)[C@H](C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,882.02 g/mol,,,0.0055
1069,etelcalcetide,C[C@H](C(=O)N[C@H](CCCN=C(N)N)C(=O)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@@H](C(=O)O)N)NC(=O)C,1048.2637 g/mol,,,
1072,midostaurin,C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,570.646 g/mol,5.5,,
1073,cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,501.5 g/mol,,,0.0055
1075,etoricoxib,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,358.848 g/mol,,,
1076,bunazosin,CCCC(=O)N1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,373.4543 g/mol,,,
1077,entacapone,CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N,305.289 g/mol,,,
1078,obeticholic acid,CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)O)C)C)O,420.63 g/mol,5.11,4.76,0.21
1079,clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,456.3197 g/mol,,,
1080,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,246.303 g/mol,,,
1082,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,335.8764 g/mol,,9.67,
1083,chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,304.215 g/mol,,,
1084,paliperidone (9-hydroxyrisperidone),CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,426.489 g/mol,,,
1086,carbazeran,CCNC(=O)OC1CCN(CC1)C2=NN=CC3=CC(=C(C=C32)OC)OC,360.412 g/mol,1.83,8.6,
1087,lovastatin acid,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C,422.558 g/mol,3.5,,
1088,cyclizine,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,266.4 g/mol,,,
1089,chlormadinone acetate,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C,404.931 g/mol,,,
1090,pilocarpine,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C,208.2594 g/mol,,,
1091,ACT-451840,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)CN([C@@H](CC3=CC=CC=C3)C(=O)N4CCN(CC4)CC5=CC=C(C=C5)C#N)C(=O)/C=C/C6=CC=C(C=C6)C(C)(C)C,750.9826 g/mol,5.2,,
1093,rilpivirine,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N,366.4 g/mol,4.32,3.26,0.02
1094,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,230.097 g/mol,,,
1095,21-desacetyl deflazacort,CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)CO,399.4841 g/mol,,,
1096,yohimbine,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,354.447 g/mol,2.73,,0.277
1097,valdecoxib,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,314.36 g/mol,,,
1098,palovarotene,CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C,414.5 g/mol,6.8,4.31,
1099,venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,277.405 g/mol,,,
1100,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,422.918 g/mol,1.19,5.5,
1101,eluxadoline,CC1=CC(=CC(=C1C[C@@H](C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)[C@@H](C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,569.65 g/mol,,7.11,0.55
1102,afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,485.9 g/mol,,,
1103,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,392.4962 g/mol,3.13,11.08,
1104,dicloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,470.331 g/mol,,,
1105,nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,565.98 g/mol,,2.1,0.29
1107,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,163.1717 g/mol,,,
1108,threohydrobupropion,CC(C(C1=CC(=CC=C1)Cl)O)NC(C)(C)C,241.76 g/mol,,,
1109,tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65,369.4 g/mol,,,
1110,pranlukast,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,481.51 g/mol,,,
1114,dextroamphetamine,C[C@@H](CC1=CC=CC=C1)N,135.21 g/mol,,,
1115,hydroxybupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)CO,255.74 g/mol,,,
1116,mesna,C(CS(=O)(=O)[O-])S.[Na+],164.18 g/mol,,,
1118,speciogynine,CC[C@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,398.4953 g/mol,,,
1120,fosdagrocorat,CC1=C(C=CC=N1)NC(=O)C2=CC3=C(C=C2)[C@@]4(CC[C@@](C[C@H]4CC3)(C(F)(F)F)OP(=O)(O)O)CC5=CC=CC=C5,574.533 g/mol,,,
1121,ibogaine,CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC,310.4384 g/mol,,,
1122,ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,434.55 g/mol,,,0.55
1124,amprenavir,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,505.633 g/mol,,,0.04
1125,ceftaroline fosamil,CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],762.7603 g/mol,,,
1126,prochlorperazine,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,373.9496 g/mol,,,
1127,cytarabine,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,243.22 g/mol,,,
1130,tramadol,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,263.379 g/mol,1.35,9.41,295
1131,pentostatin,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O,268.27 g/mol,,,
1132,pridopidine,CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C,281.4177 g/mol,,,
1134,almorexant,CNC(=O)[C@@H](C1=CC=CC=C1)N2CCC3=CC(=C(C=C3[C@@H]2CCC4=CC=C(C=C4)C(F)(F)F)OC)OC,512.5689 g/mol,,,
1135,ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,255.272 g/mol,,,
1137,triclabendazole sulfoxide,CS(=O)C1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,375.7 g/mol,,,
1138,vortioxetine,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,379.36 g/mol,,,0.55
1139,terlipressin,C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,1227.3856 g/mol,,,
1143,cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,776.0347 g/mol,,,
1144,sofosbuvir,C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,529.4551 g/mol,1,9.3,
1147,moxifloxacin,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,401.436 g/mol,,,
1149,dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,488.01 g/mol,,,
1150,flibanserin,C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F,390.41 g/mol,,,0.008
1151,belinostat,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO,318.35 g/mol,,,
1152,venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,868.44 g/mol,,,
1153,apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,459.5035 g/mol,,,
1154,butorphanol,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,327.465 g/mol,,,
1155,sacubitril,CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,411.4951 g/mol,,,
1156,regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,500.83 g/mol,,,0.055
1157,ospemifene (deamino-hydroxytoremifene),C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\C3=CC=C(C=C3)OCCO)/CCCl,378.90 g/mol,,,
1158,trifluridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,296.2 g/mol,,,
1159,BMS-823778,CC(C)(C1=CC=CN2C1=NN=C2C3(CC3)C4=CC=C(C=C4)Cl)O,327.808 g/mol,2.76,3.5,
1161,topiramate,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,339.4 g/mol,0.57,8.61,9.8
1162,roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,403.2106 g/mol,3.99,,0.00054
1163,rufloxacin,CN1CCN(CC1)C2=C(C=C3C4=C2SCCN4C=C(C3=O)C(=O)O)F,363.4112 g/mol,,,
1164,ponesimod,CCCN=C1N(C(=O)/C(=C/C2=CC(=C(C=C2)OC[C@@H](CO)O)Cl)/S1)C3=CC=CC=C3C,460.9795 g/mol,,,0.055
1165,promazine,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,284.425 g/mol,,,
1166,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,265.3581 g/mol,,,
1167,upadacitinib,CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F,380.3721 g/mol,,,
1169,sirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,914.179 g/mol,,,
1170,clopidogrel,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,321.826 g/mol,,5.3,
1171,ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,331.346 g/mol,,,
1172,cangrelor,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O,776.3615 g/mol,,,
1173,basimglurant,CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl,325.7727 g/mol,,,
1174,ivermectin,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,1736.1704 g/mol,,,
1175,enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,473.3793 g/mol,,,
1176,troglitazone,CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C,441.545 g/mol,,,0.0055
1177,benazepril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,424.494 g/mol,,,
1178,idarubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,497.497 g/mol,,,
1179,praziquantel,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,312.411 g/mol,,,
1180,2-(1-piperazinyl)pyrimidine,C1CN(CCN1)C2=NC=CC=N2,164.21 g/mol,,,
1181,gemigliptin,C1CC(CN(C1=O)C[C@H](CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F,489.4 g/mol,,,
1182,clarithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,747.957 g/mol,,,
1183,voclosporin,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1214.62 g/mol,5.87,,0.0055
1184,prasugrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,373.446 g/mol,,,0.0055
1185,gallic acid,C1=C(C=C(C(=C1O)O)O)C(=O)O,170.1194 g/mol,,,
1187,albiglutide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC6=CNC=N6)N,72970 g/mol,,,
1188,telbivudine,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,242.229 g/mol,,,
1189,quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,383.5 g/mol,,,
1190,repaglinide,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,452.591 g/mol,,,
1192,voriconazole,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,349.3 g/mol,,,
1194,naloxegol,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC=C)O,742 (oxalate form) g/mol,-1,,
1195,disufenton sodium,CC(C)(C)/[N+](=C/C1=C(C=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])/[O-].[Na+].[Na+],381.336 g/mol,,,
1198,zavegepant,CC1=CC(=CC2=C1NN=C2)C[C@H](C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O,638.8 g/mol,,4.8,
1206,capmatinib,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,412.4263 g/mol,,4.5,
1219,remdesivir,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,602.5815 g/mol,-2.31,,
1220,trofinetide,C[C@]1(CCCN1C(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)O,315.32 g/mol,,8.61,
1225,raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,473.59 g/mol,,,
1226,zoniporide,C1CC1C2=C(C=NN2C3=CC=CC4=C3C=CC=N4)C(=O)N=C(N)N,320.3544 g/mol,1.15,,
1228,remimazolam,CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=N[C@H]2CCC(=O)OC)C4=CC=CC=N4,439.3 g/mol,,,5.5
1232,bempedoic acid,CC(C)(CCCCCC(CCCCCC(C)(C)C(=O)O)O)C(=O)O,344.5 g/mol,0.8,4.88,
1238,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,531.437 g/mol,4.3,,
1239,idelalisib,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,415.42 g/mol,,1.6,0.055
1254,balovaptan,CN1CC2=C(C=CC(=C2)Cl)N3C(=NN=C3C4CCC(CC4)OC5=CC=CC=N5)C1,409.9186 g/mol,,,
1255,eslicarbazepine,C1[C@@H](C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,254.2876 g/mol,,,0.055
1262,lenacapavir,CC(C)(C#CC1=NC(=C(C=C1)C2=C3C(=C(C=C2)Cl)C(=NN3CC(F)(F)F)NS(=O)(=O)C)[C@H](CC4=CC(=CC(=C4)F)F)NC(=O)CN5C6=C([C@H]7C[C@H]7C6(F)F)C(=N5)C(F)(F)F)S(=O)(=O)C,968.3 g/mol,5.1,6.8,
1268,pimobendan,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC,334.3772 g/mol,,,
1270,abrocitinib,CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3,323.4138 g/mol,1.66,5.3,0.04
1271,melphalan,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,305.203 g/mol,0.33,2.5,
1279,bitopertin,C[C@@H](C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CCN(CC2)C3=C(C=C(C=N3)C(F)(F)F)F,543.458 g/mol,3.03,,
1281,amisulpride,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,369.483 g/mol,,,0.0055
1282,riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,422.42 g/mol,,,0.004
1284,ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,558.14 g/mol,,,
1285,almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,469.56 g/mol,,,
1286,sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,279.85 g/mol,,,
1288,indacaterol,CCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,392.49 g/mol,,7.3,0.23
1291,mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,444.485 g/mol,,,
1295,genistein,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,270.239 g/mol,,,
1298,telavancin,CCCCCCCCCCNCCN[C@]1(C[C@@H](O[C@H]([C@H]1O)C)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)C,1755.6474 g/mol,,,
1299,eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,442.5 g/mol,,,
1301,selonsertib,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,445.4996 g/mol,,,
1303,filociclovir,C1/C(=C/N2C=NC3=C2N=C(NC3=O)N)/C1(CO)CO,263.2557 g/mol,,,
1312,uridine triacetate,CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C,370.3122 g/mol,,,
1323,etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,435.28 g/mol,,,0.0055
1328,cenobamate,C1=CC=C(C(=C1)[C@H](CN2N=CN=N2)OC(=O)N)Cl,267.675 g/mol,,,
1329,mizolastine,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,432.5 g/mol,,,
1332,elexacaftor,C[C@H]1CC(N(C1)C2=C(C=CC(=N2)N3C=CC(=N3)OCC(C)(C)C(F)(F)F)C(=O)NS(=O)(=O)C4=CN(N=C4C)C)(C)C,597.6596 g/mol,,,0.055
1336,tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,572.7456 g/mol,2.82,,
1342,pexidartinib,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,417.8205 g/mol,,2.6,0.347
1345,deucravacitinib,[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4,425.459 g/mol,,3.4,
1352,dimetindene,CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C,292.4236 g/mol,,,
1357,valbenazine,CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC,418.57 g/mol,,,
1359,bismuth,[Bi],208.98 g/mol,,,
1366,cevimeline,C[C@@H]1O[C@]2(CN3CCC2CC3)CS1,244.79 g/mol,,,550
1368,ridogrel,C1=CC(=CC(=C1)C(F)(F)F)/C(=N\OCCCCC(=O)O)/C2=CN=CC=C2,366.3373 g/mol,,,
1401,taletrectinib,C[C@H](COC1=CC=C(C=C1)C2=CN=C3N2N=C(C=C3)N[C@H](C)C4=CC(=CC=C4)F)N.C(CCC(=O)O)CC(=O)O,405.468 g/mol,,,
1403,posaconazole,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,700.8 g/mol,,,
1424,letermovir,COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,572.55 g/mol,4.6,,
1437,rimegepant,C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6,534.5642 g/mol,0.8,,
1438,lutetium Lu-177 vipivotide tetraxetan,C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O.[177Lu+3],1216.1 g/mol,,,
1441,avadomide,CC1=NC2=CC=CC(=C2C(=O)N1C3CCC(=O)NC3=O)N,286.2896 g/mol,,,
1442,SUVN-G3031,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)NC(=O)CN4CCOCC4,373.4891 g/mol,,,
1447,hippuric acid,C1=CC=C(C=C1)C(=O)NCC(=O)O,179.17 g/mol,,,
1448,encorafenib,C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC,540.0173 g/mol,2.59,4.51,
1450,pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,487.5043 g/mol,2.2,5.7,
1453,mitapivat,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,450.6 g/mol,,,2.09
1462,ubrogepant,C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6,549.5504 g/mol,,,0.0055
1473,mobocertinib,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,585.6966 g/mol,4.65,2.5,
1477,simurosertib,CC1=C(C=NN1)C2=CC3=C(S2)C(=O)NC(=N3)[C@@H]4CC5CCN4CC5,341.4307 g/mol,,,
1482,fluticasone furoate,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F,538.5801 g/mol,,,
1485,razuprotafib,COC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)NS(=O)(=O)O)C3=CSC(=N3)C4=CC=CS4,586.7114 g/mol,,,15
1493,opelconazole,CC1=C(C=CC(=C1)N2CCN(CC2)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)F)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,682.734 g/mol,,,
1503,tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,480.5296 g/mol,,2.07,
1510,talazoparib,CN1C(=NC=N1)[C@@H]2[C@H](NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,380.3566 g/mol,,,0.0275
1517,pimavanserin,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,427.55 g/mol,4.67,8.6,
1527,pralsetinib,CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC,533.6088 g/mol,3.87,6.71,
1531,urapidil,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,387.481 g/mol,,,
1533,adagrasib,CN1CCC[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F,604.1 g/mol,5.02,3.33,0.0055
1540,lubiprostone,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F,390.46 g/mol,,,
1541,secnidazole,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],185.18 g/mol,,,
1542,ripretinib,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,510.3649 g/mol,3.7,,
1547,nirmatrelvir,CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)C(F)(F)F)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)C,499.5265 g/mol,1.84,,
1550,atogepant,C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=C(C=CC(=C6F)F)F,603.5207 g/mol,,,0.0055
1551,biperiden,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,311.5 g/mol,,,
1556,fostemsavir,CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC,583.4954 g/mol,,,
1558,olverembatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CC5=C(NN=C5)N=C4,532.6 g/mol,3.6,2.9,
1561,ropivacaine,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C,274.405 g/mol,,,
1568,selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,525.6099 g/mol,,3.19,
1569,temsavir,CC1=NN(C=N1)C2=NC=C(C3=C2NC=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)OC,473.4907 g/mol,,,
1571,voxelotor,CC(C)N1C(=CC=N1)C2=C(C=CC=N2)COC3=CC=CC(=C3C=O)O,337.3771 g/mol,,,0.03
1577,lasmiditan,CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F,377.3642 g/mol,,,
1578,avacopan,CC1=C(C(=CC=C1)F)C(=O)N2CCC[C@@H]([C@@H]2C3=CC=C(C=C3)NC4CCCC4)C(=O)NC5=CC(=C(C=C5)C)C(F)(F)F,581.6505 g/mol,,4.7,0.0055
1581,sotorasib,C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,560.6 g/mol,,8.06,
1585,oliceridine,COC1=C(SC=C1)CNCC[C@]2(CCOC3(C2)CCCC3)C4=CC=CC=N4,386.557 g/mol,,,5.5
1592,somapacitan,C(CCCCCCCC1=NNN=N1)CCCCCCCC(=O)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)N[C@@H](CCCCNC(=O)CSC[C@@H](C(=O)O)N)C(=O)N)C(=O)O)C(=O)O,1310.5475 g/mol,,,
1593,moclobemide,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,268.742 g/mol,,6.2,
1597,ulimorelin,C[C@@H]1CN[C@H](C(=O)N([C@@H](C(=O)N[C@@H](C(=O)NCCCC2=CC=CC=C2O1)CC3=CC=C(C=C3)F)C)C)C4CC4,538.6601 g/mol,,,
1605,adinazolam,CN(C)CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,351.8 g/mol,,,
1610,mifepristone,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,429.6 g/mol,5.13,5,
1616,teriflunomide,C/C(=C(\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O,270.21 g/mol,,3.1,0.02
1625,erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,446.552 g/mol,,,0.0055
1627,larotrectinib,C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F,428.4408 g/mol,1.7,2,
1630,esomeprazole,CC1=CN=C(C(=C1OC)C)C[S@](=O)C2=NC3=C(N2)C=C(C=C3)OC,345.42 g/mol,,9.29,0.36
1634,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,357.432 g/mol,,,
1639,flavopiridol (alvocidib),CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,401.844 g/mol,,,
1645,tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,448.948 g/mol,5,,
1647,lurbinectedin,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O,784.9 g/mol,,,
1649,landiolol,CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C,509.596 g/mol,,,
1656,cabotegravir,C[C@H]1CO[C@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,405.3553 g/mol,1.58,7.8,2.9
1661,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,430.37 g/mol,2.49,12,0.005
1671,TP0463518,C1CN(C(=O)C(=C1O)C(=O)NCC(=O)O)CC2=CN=C(C=C2)OC3=CC=C(C=C3)Cl,431.8 g/mol,,,
1676,apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,477.4405 g/mol,2.89,9.7,
1687,navtemadlin,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,568.5522 g/mol,,4.35,
1694,7-ethyl-10-hydroxycamptothecin (SN-38),CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O,392.409 g/mol,,,
1697,gepirone,CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=NC=CC=N3)C,359.5 g/mol,,,
1698,salicin,C1=CC=C(C(=C1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,286.2782 g/mol,-0.86,,
1701,tauroobeticholic acid,CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)NCCS(=O)(=O)O)C)C)O,527.8 g/mol,,,
1704,saquinavir,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,670.85 g/mol,,,
1705,rocuronium,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,529.7807 g/mol,,,
1710,sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,386.557 g/mol,,,
1712,omadacycline,CC(C)(C)CNCC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,556.656 g/mol,,,
1713,dapoxetine,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3,305.419 g/mol,,8.6,
1717,cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,388.892 g/mol,,,
1718,lactitol,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,344.3106 g/mol,,,
1720,omaveloxolone,C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F,554.7 g/mol,,7.26,0.0055
1723,belumosudil,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,452.5156 g/mol,3.8,1.57,0.0055
1726,rufinamide,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,238.196 g/mol,,,
1731,olodaterol,CC(C)(CC1=CC=C(C=C1)OC)NC[C@@H](C2=C3C(=CC(=C2)O)NC(=O)CO3)O,"422.9 (salt), 386.5 (base) g/mol",,,
1732,avanafil,COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCC[C@H]4CO)Cl,483.9574 g/mol,,,0.0055
1752,tirzepatide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CCCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CC=C(C=C8)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=CC=C9)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N,4813.53 g/mol,,,
1753,ramelteon,CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3,259.347 g/mol,,,
1754,idasanutlin,CC(C)(C)C[C@H]1[C@]([C@H]([C@@H](N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,616.4891 g/mol,,4,
1757,nemiralisib,CC(C)N1CCN(CC1)CC2=CN=C(O2)C3=C4C=NNC4=CC(=C3)C5=C6C=CNC6=CC=C5,440.5482 g/mol,4.01,8.47,
1763,trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,371.87 g/mol,2.9,6.74,
1767,belzutifan,CS(=O)(=O)C1=C2[C@@H]([C@@H]([C@@H](C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,383.3417 g/mol,,,0.01
1774,avapritinib,C[C@](C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,498.558 g/mol,3.2,6.97,
1788,remdesivir metabolite GS-441524,C1=C2C(=NC=NN2C(=C1)[C@]3([C@@H]([C@@H]([C@H](O3)CO)O)O)C#N)N,291.2627 g/mol,,,
1792,estetrol,C[C@]12CC[C@H]3[C@H]([C@@H]1[C@H]([C@H]([C@@H]2O)O)O)CCC4=C3C=CC(=C4)O,304.3836 g/mol,,,0.308
1795,7-carboxycannabidiol (cannabidiol-11-oic acid),CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C(=O)O)O,344.4 g/mol,,,
1796,gadopiclenol,C1CN(CC2=NC(=CC=C2)CN(CCN1C(CCC(=O)NCC(CO)O)C(=O)[O-])C(CCC(=O)NCC(CO)O)C(=O)[O-])C(CCC(=O)NCC(CO)O)C(=O)[O-].[Gd+3],970.0912 g/mol,,,
1803,inavolisib,C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F,407.37 g/mol,0.96,3.12,
1811,tiagabine,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C,375.555 g/mol,,,
1815,fluzoparib,C1CN2C(=NC(=N2)C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,472.4004 g/mol,,,
1816,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,432.4 g/mol,2.05,3.92,
1827,lefamulin,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CS[C@@H]4CC[C@H](C[C@H]4O)N)C,567.79 g/mol,4.3,,
1828,enerisant,C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)N3C=C(C=N3)C(=O)N4CCOCC4,398.504 g/mol,,9.42,
1831,pemafibrate,CC[C@H](C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3,490.553 g/mol,5.04,3.58,
1834,gisadenafil,CCC1=C2C(=NN1CCOC)C(=O)NC(=N2)C3=C(N=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC,519.6237 g/mol,,,
1841,roflumilast N-oxide,C1CC1COC2=C(C=CC(=C2)C(=O)N=C3C(=CN(C=C3Cl)O)Cl)OC(F)F,419.2 g/mol,,,
1850,casimersen,CN(C)P(=O)(N1CCN(CC1)C(=O)OCCOCCOCCO)OC[C@@H]2CNC[C@@H](O2)N3C=CC(=NC3=O)N,7584.5 g/mol,,,
1851,etrasimod,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CC[C@@H]5CC(=O)O)C(F)(F)F,457.5 g/mol,7.4,4.5,
1867,ropeginterferon alfa-2b,COCCOC(=O)NCCCCC(CCN1CCC[C@H]1C(=O)O)NC(=O)OCCOC,60000 g/mol,-1.3,,
1878,futibatinib,COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)[C@H]4CCN(C4)C(=O)C=C)OC,418.4485 g/mol,3.3,3.24,
1879,verinurad,CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N,348.4244 g/mol,,,
1880,ipatasertib,C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O,458.0028 g/mol,2.5,9,
1884,osthole (Cnidium monnieri),CC(=CCC1=C(C=CC2=C1OC(=O)C=C2)OC)C,244.288 g/mol,,,
1888,degrasyn,CCC[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N,384.3 g/mol,,,
1891,zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,424.4394 g/mol,,,
1893,halofuginone,C1C[C@H]([C@@H](NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O,414.6853 g/mol,,,
1894,GST-HG131,CC(C)(C)[C@@H]1COC2=CC(=C(C=C2C3=CC(=O)C(=CN13)C(=O)O)OC)OCCCOC,431.5 g/mol,,,
1900,nemonoxacin,C[C@H]1C[C@@H](CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N,371.4345 g/mol,,,
1909,tolamolol,CC1=CC=CC=C1OCC(CNCCOC2=CC=C(C=C2)C(=O)N)O,344.409 g/mol,,,
1926,bictegravir,C1C[C@@H]2C[C@H]1N3[C@H](O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,471.4 g/mol,2.1,8.3,0.1
1934,ceftobiprole,C1CNC[C@@H]1N2CC/C(=C\C3=C(N4[C@@H]([C@@H](C4=O)NC(=O)/C(=N\O)/C5=NSC(=N5)N)SC3)C(=O)O)/C2=O,534.6 g/mol,,,
1957,speciociliatine,CC[C@@H]1CN2CCC3=C([C@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,398.5 g/mol,,,
1965,zuranolone,C[C@]1(CC[C@H]2[C@@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CN5C=C(C=N5)C#N)C)O,409.57 g/mol,,,0.0055
1969,dienogest,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O,311.422 g/mol,,,
1971,iloperidone,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,426.5 g/mol,,,
1974,napabucasin,CC(=O)C1=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O,240.2132 g/mol,2.3,,
1979,remibrutinib,CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C,507.5318 g/mol,2.8,4.1,
1983,resminostat,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)/C=C/C(=O)NO,349.4091 g/mol,,,
1989,sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC,592.8 g/mol,4.26,4.09,0.55
1994,pecazine,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,310.4628 g/mol,,,
1998,ceftazidime and avibactam,CC(C)(C(=O)O)O/N=C(\C1=CSC(=N1)N)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-].C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)N,636.6 g/mol,,,
1999,entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,560.6456 g/mol,,2.54,
2016,felcisetrag,CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC4CCN(CC4)C(=O)OC,455.5993 g/mol,,,
2023,vidofludimus,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,355.3632 g/mol,,,
2027,valemetostat,CC1=CC(=C(C(=O)N1)CNC(=O)C2=CC(=C3C(=C2C)O[C@@](O3)(C)C4CCC(CC4)N(C)C)Cl)C,488 g/mol,,,
2028,pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,437.5257 g/mol,,2.1,
2036,lazertinib,CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,554.6428 g/mol,4.38,2.2,
2045,micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O,1292.26 g/mol,,,
2048,vericiguat,COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N,426.3854 g/mol,,4.7,
2053,ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,237.728 g/mol,,,
2054,mepivacaine,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,246.3518 g/mol,,,
2057,gepotidacin,C1CC2=CC(=NC=C2OC1)CNC3CCN(CC3)C[C@@H]4CN5C(=O)C=CC6=C5N4C(=O)C=N6,448.5242 g/mol,0.16,8.83,
2063,verlukast,CN(C)C(=O)CCS[C@@H](C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O,515.0953 g/mol,,,
2065,loratadine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,382.889 g/mol,5.2,,
2067,oxandrolone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C,306.443 g/mol,4.2,,
2072,difelikefalin,CC(C)C[C@H](C(=O)N[C@H](CCCCN)C(=O)N1CCC(CC1)(C(=O)O)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC3=CC=CC=C3)N,679.8577 g/mol,,2.4,
2073,gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,552.7196 g/mol,,,29
2074,abexinostat,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,397.4287 g/mol,,,
2075,imeglimin,C[C@@H]1N=C(NC(=N1)N(C)C)N,155.2037 g/mol,,,
2085,voxilaprevir,CC[C@@H]1[C@@H]2CN([C@@H]1C(=O)N[C@@]3(C[C@H]3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)[C@@H](NC(=O)O[C@@H]5C[C@H]5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C,868.9418 g/mol,,,
2099,moricizine,CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4,427.5225 g/mol,,6.4,
2102,reboxetine,CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3,313.4 g/mol,,,
2109,talampanel,C[C@@H]1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,337.377 g/mol,,,
2115,selinexor,C1=CN=C(C=N1)NNC(=O)/C=C\N2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,443.3099 g/mol,,,
2117,midecamycin,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C,813.9723 g/mol,,,
2118,cedazuridine,C1CN(C(=O)N[C@@H]1O)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,268.2146 g/mol,,,
2125,laquinimod,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,356.8073 g/mol,3.7,,
2128,azelnidipine,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,582.65 g/mol,4.43,1.9,
2133,rezafungin,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)OCC[N+](C)(C)C)O,1226.4 g/mol,,,
2140,iptacopan,CCO[C@H]1CCN([C@@H](C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC,422.5 g/mol,,,10.78
2148,infigratinib,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,560.4829 g/mol,4.7,,
2150,1'-hydroxymidazolam,C1C2=CN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4F)CO,341.7717 g/mol,,,
2152,janagliflozin,C1[C@H]2[C@@H]1CC(C2)OC3=CC=C(C=C3)CC4=C(C=CC(=C4)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)Cl,460.9511 g/mol,3.5,,0.07
2156,nivasorexant,CC1=CC(=C(C=C1)C(=O)N2CCOC[C@H]2CC3=CC(=CC=C3)N4N=CC=N4)N5N=CC=N5,429.5 g/mol,,,0.0055
2168,apararenone,CC1(C(=O)N(C2=C(O1)C=C(C=C2)NS(=O)(=O)C)C3=CC=C(C=C3)F)C,364.3953 g/mol,,,
2172,molibresib,CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,423.9 g/mol,2.38,,
2177,repotrectinib,C[C@H]1CNC(=O)C2=C3N=C(C=CN3N=C2)N[C@@H](C4=C(O1)C=CC(=C4)F)C,355.37 g/mol,3.49,,0.007
2178,lumacaftor,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,452.41 g/mol,4.4,,
2197,MAK-683,CC1=C(C=CC=N1)C2=CN=C(N3C2=NN=C3)NCC4=C(C=CC5=C4CCO5)F,376.387 g/mol,,,7.15E-06
2199,cariprazine,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,463.9 g/mol,4.428,8.182,1.30E-09
2200,GSK269984A,C1=CC(=NC(=C1)C(=O)[O-])CC2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)Cl)F.[Na+],428.216 g/mol,,,
2207,volasertib,CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,618.822 g/mol,,,
2212,rivipansel,C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H](C[C@H](C[C@H]2O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@@H](CC4CCCCC4)C(=O)O)OC(=O)C5=CC=CC=C5)C(=O)NCCNC(=O)COCCOCC(=O)NC6=C7C(=CC(=C6)S(=O)(=O)O)C=C(C=C7S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)O)O)O,1447.4316 g/mol,,,
2215,tezacaftor,CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,520.5013 g/mol,,13.99,
2216,antazoline,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3,265.3581 g/mol,,,
2224,tirbanibulin,C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4,431.5331 g/mol,,,
2226,CUDC-101,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,434.4934 g/mol,,,
2229,vadadustat,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,306.70 g/mol,,,0.0055
2235,tazobactam,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,300.294 g/mol,,,
2240,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,194.15 g/mol,,,
2244,zanubrutinib,C=CC(=O)N1CCC(CC1)[C@@H]2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,471.5509 g/mol,4.2,3.3,0.052
2267,ASP4345,CN(CC1=NC2=C(N1)C=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(C=CC(=C4)Cl)OC3=O,438.8 g/mol,,,
2269,lemborexant,CC1=NC(=NC=C1OC[C@]2(C[C@H]2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,410.422 g/mol,3.7,3.5,
2272,metopimazine,CS(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)C(=O)N,445.6053 g/mol,,,
2282,amocarzine,CN1CCN(CC1)C(=S)NC2=CC=C(C=C2)NC3=CC=C(C=C3)[N+](=O)[O-],371.463 g/mol,,6.8,
2287,rotigotine,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O,315.48 g/mol,,,
2290,N-desmethylclobazam,C1C(=O)NC2=C(C=C(C=C2)Cl)N(C1=O)C3=CC=CC=C3,286.71 g/mol,,,
2292,plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,502.7906 g/mol,,,
2299,fosdevirine,CC1=CC(=CC(=C1)[P@@](=O)(C2=C(NC3=C2C=C(C=C3)Cl)C(=O)N)OC)/C=C/C#N,413.794 g/mol,,,
2305,sotagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O)Cl,424.94 g/mol,,,0.0055
2325,ethionamide,CCC1=NC=CC(=C1)C(=S)N,166.244 g/mol,,,
2326,(d)-nebivolol,C1CC2=C(C=CC(=C2)F)O[C@H]1[C@@H](CNC[C@H]([C@@H]3CCC4=C(O3)C=CC(=C4)F)O)O,405.4 g/mol,,,
2332,cefiderocol,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5=C(C(=C(C=C5)O)O)Cl)C(=O)[O-],752.21 g/mol,,,
